TY - JOUR T1 - COVID-19 reopening strategies at the county level in the face of uncertainty: Multiple Models for Outbreak Decision Support JF - medRxiv DO - 10.1101/2020.11.03.20225409 SP - 2020.11.03.20225409 AU - Katriona Shea AU - Rebecca K. Borchering AU - William J.M. Probert AU - Emily Howerton AU - Tiffany L. Bogich AU - Shouli Li AU - Willem G. van Panhuis AU - Cecile Viboud AU - Ricardo Aguás AU - Artur Belov AU - Sanjana H. Bhargava AU - Sean Cavany AU - Joshua C. Chang AU - Cynthia Chen AU - Jinghui Chen AU - Shi Chen AU - YangQuan Chen AU - Lauren M. Childs AU - Carson C. Chow AU - Isabel Crooker AU - Sara Y. Del Valle AU - Guido España AU - Geoffrey Fairchild AU - Richard C. Gerkin AU - Timothy C. Germann AU - Quanquan Gu AU - Xiangyang Guan AU - Lihong Guo AU - Gregory R. Hart AU - Thomas J. Hladish AU - Nathaniel Hupert AU - Daniel Janies AU - Cliff C. Kerr AU - Daniel J. Klein AU - Eili Klein AU - Gary Lin AU - Carrie Manore AU - Lauren Ancel Meyers AU - John Mittler AU - Kunpeng Mu AU - Rafael C. Núñez AU - Rachel Oidtman AU - Remy Pasco AU - Ana Pastore y Piontti AU - Rajib Paul AU - Carl A. B. Pearson AU - Dianela R. Perdomo AU - T Alex Perkins AU - Kelly Pierce AU - Alexander N. Pillai AU - Rosalyn Cherie Rael AU - Katherine Rosenfeld AU - Chrysm Watson Ross AU - Julie A. Spencer AU - Arlin B. Stoltzfus AU - Kok Ben Toh AU - Shashaank Vattikuti AU - Alessandro Vespignani AU - Lingxiao Wang AU - Lisa White AU - Pan Xu AU - Yupeng Yang AU - Osman N. Yogurtcu AU - Weitong Zhang AU - Yanting Zhao AU - Difan Zou AU - Matthew Ferrari AU - David Pannell AU - Michael Tildesley AU - Jack Seifarth AU - Elyse Johnson AU - Matthew Biggerstaff AU - Michael Johansson AU - Rachel B. Slayton AU - John Levander AU - Jeff Stazer AU - Jessica Salerno AU - Michael C. Runge Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/05/2020.11.03.20225409.abstract N2 - Policymakers make decisions about COVID-19 management in the face of considerable uncertainty. We convened multiple modeling teams to evaluate reopening strategies for a mid-sized county in the United States, in a novel process designed to fully express scientific uncertainty while reducing linguistic uncertainty and cognitive biases. For the scenarios considered, the consensus from 17 distinct models was that a second outbreak will occur within 6 months of reopening, unless schools and non-essential workplaces remain closed. Up to half the population could be infected with full workplace reopening; non-essential business closures reduced median cumulative infections by 82%. Intermediate reopening interventions identified no win-win situations; there was a trade-off between public health outcomes and duration of workplace closures. Aggregate results captured twice the uncertainty of individual models, providing a more complete expression of risk for decision-making purposes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge support from NSF COVID-19 RAPID awards 2028301 and 2037885, the Huck Institutes for the Life Sciences at The Pennsylvania State University, the National Institutes of Health, and the U.S. Geological Survey. WJMP is funded by the Li Ka Shing Foundation. Wilbert G Van Panhuis, John Levander, Jeff Stazer, and Jessica Salerno are funded by the MIDAS Coordination Center (U24GM132013).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Modeling study, which does not require IRB approvalAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is a modeling paper; a Github repository for the code and estimates will be provided. ER -